Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer
Douglas G. McNeel, Hamid Emamekhoo, Jens C. Eickhoff, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e008067-e008067
Open Access | Times Cited: 16

Showing 16 citing articles:

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Fan Guan, Ruixuan Wang, Zhenjie Yi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
The Immune Microenvironment in Prostate Cancer: A Comprehensive Review
René Novysedlák, Miray Guney, Majd Al Khouri, et al.
Oncology (2024), pp. 1-25
Open Access | Times Cited: 9
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Advances in nucleic acid-based cancer vaccines
Hung‐Chun Liao, Shih‐Jen Liu
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1
Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance
Caihong Li, Dongkai Cheng, Peng Li
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
Sequence of androgen receptor-targeted vaccination with androgen deprivation therapy affects anti-prostate tumor efficacy
Anusha Muralidhar, Melissa Gamat, Sita Vakkalanka, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 5, pp. e008848-e008848
Open Access | Times Cited: 4
Nanoparticle-mediated enhancement of DNA Vaccines: Revolutionizing immunization strategies
Pegah Yaraghi, Abbas Kheyri, Narges Mikaeili, et al.
International Journal of Biological Macromolecules (2025) Vol. 302, pp. 140558-140558
Closed Access
Recent Advances in the Development and Efficacy of Anti-Cancer Vaccines—A Narrative Review
Kajetan Kiełbowski, Paulina Plewa, Jan Zadworny, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 237-237
Open Access
The application of emerging immunotherapy in the treatment of prostate cancer: progress, dilemma and promise
Jizhong Che, Yuanyuan Liu, Yangyang Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
mRNA vaccines for prostate cancer: A novel promising immunotherapy
Yaxiong Tang, Xianyanling Yi, Jianzhong Ai
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189333-189333
Closed Access
Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients
David J. Einstein, Jeanny B. Aragon‐Ching, Fatima Karzai, et al.
Current Opinion in Oncology (2024) Vol. 36, Iss. 3, pp. 164-168
Closed Access | Times Cited: 3
Cancer Vaccines: Recent Insights and Future Directions
Aretia-Teodora Malacopol, Peter Johannes Holst
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11256-11256
Open Access | Times Cited: 2
New insights for the development of efficient DNA vaccines
Simone Berger, Yanira Zeyn, Ernst Wagner, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 11
Open Access | Times Cited: 2
Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer
Tommaso P Tonelli, Jens C. Eickhoff, Laura E. Johnson, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Unlocking Immunity: Innovative prostate cancer vaccine strategies
Qiannan Gu, Anning Qi, Ne Wang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113137-113137
Closed Access | Times Cited: 1
Are Novice Resident Physicians Capable of Executing Freehand Cognitive Fusion Transperineal Prostate Biopsies ?
Yize Guo, Bin Li, Yongchao Yan, et al.
Research Square (Research Square) (2024)
Closed Access
Bioinformatics Analysis and Immunogenicity Assessment of the Novel Multi‐Stage DNA Vaccine W541 Against Mycobacterium Tuberculosis
Yourong Yang, Yong Xue, Xiaoou Wang, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 11
Open Access
Synergistic effects of immunotherapy and adjunctive therapies in prostate cancer management
Jie Chen, Na Ma, Bo Chen, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 207, pp. 104604-104604
Open Access
Page 1

Scroll to top